Live feed07:59:13·88dANALYSTRatingvia QuantisnowGuggenheim initiated coverage on Sagimet Biosciences with a new price targetByQuantisnow·Wall Street's wire, on your screen.SGMT· Sagimet Biosciences Inc.Health CareOriginal source